阿里巴巴(09988.HK就「双11」商标注册上诉案被驳回
阿里巴巴(09988.HK)与国家知识产权局就诉争商标为阿里巴巴於2019年1月申请注册的「双11」商标,二审颁布行政判决书。
二审判决书显示,诉争商标由文字「双11」构成,整体易被理解为「十一月十一日」,在实际使用中相关公众易将其识别为用於表示某一特定日期。诉争商标指定使用在复审服务上,相关公众难以将其识别为标示复审服务来源的商标,缺乏显着性。二审庭审判决驳回上诉。
一审法院认为,阿里巴巴提交的证据尚不足以证明诉争商标经使用已在复审服务上获得可供注册的显着性,且提出的其他商标获准注册的事实与本案情况不同,不能作为诉争商标应当予以初步审定公告的当然依据。故判决驳回阿里巴巴诉讼请求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.